CEVA SANTE ANIMALE SA has a total of 54 patent applications. Its first patent ever was published in 2004. It filed its patents most often in France, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are CLEMENTIA PHARMACEUTICALS INC, STREMMEL WOLFGANG and MEDGENE BIOSCIENCE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 8 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Hungary | 5 | |
#5 | Mexico | 5 | |
#6 | United States | 5 | |
#7 | Australia | 3 | |
#8 | Canada | 2 | |
#9 | China | 2 | |
#10 | South Africa | 2 | |
#11 | Brazil | 1 | |
#12 | Hong Kong | 1 | |
#13 | Israel | 1 | |
#14 | Morocco | 1 | |
#15 | Netherlands | 1 | |
#16 | Norway | 1 | |
#17 | New Zealand | 1 | |
#18 | Russian Federation | 1 | |
#19 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry | |
#4 | Measurement | |
#5 | Machines | |
#6 | Surface technology and coating | |
#7 | Packaging and shipping |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Preservation of human bodies | |
#5 | Peptides | |
#6 | Analysing materials | |
#7 | Shaping of plastics | |
#8 | Containers for goods storage | |
#9 | Layered products | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Bertaim Thierry | 12 |
#2 | Floch Stephane | 12 |
#3 | Lagarde Anouck | 12 |
#4 | Gardin Yannick | 6 |
#5 | Palya Vilmos | 6 |
#6 | Comte Sylvain | 6 |
#7 | Forget Patrick | 5 |
#8 | Cilliers Hannelie | 5 |
#9 | Guyonnet Jerome | 4 |
#10 | Del Bigio Mauricio | 4 |
Publication | Filing date | Title |
---|---|---|
AU2013204272A1 | Veterinary Antiprolactinic Composition for Ruminants | |
WO2012107585A1 | Novel concentrated and stable topical antiparasitic compositions | |
WO2012001083A2 | Novel eprinomectin injectable compositions | |
US2011092560A1 | Topical composition for controlling ectoparasites in dogs and cats | |
US2009270356A1 | Compositions and treatments of heart failure in non-human mammal animals | |
FR2925334A1 | NEW ANTIBACTERIAL COMPOSITIONS | |
FR2917975A1 | Compositions and treatment of cardiac insufficiency in non-human mammal animals | |
FR2917381A1 | Multilayer plastic packaging for preserving a pharmaceutical composition | |
FR2911506A1 | PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION IN THE FORM OF STABILIZED AQUEOUS SUSPENSIONS | |
FR2909558A1 | PROCESS FOR PRODUCING MEDICAMENT PREMISES | |
FR2889873A1 | METHOD OF DETECTING PROGESTERONE IN COW MILK AND CORRESPONDING KIT | |
FR2880273A1 | PROCESS FOR SEPARATING A SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE AND CONTROLLED AT HIGH PRESSURES | |
FR2874324A1 | ORAL ANTIBACTERIAL VETERINARY COMPOSITION BASED ON LACTIC ACID AND FORMIC ACID |